Summary
34 / 100 · Bulios Score
What speaks for it
- Revenue grew by 16% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- Out of every 100 CNY of revenue, only 1.4 CNY is left as net profit.
- It earns only 1.2 CNY a year on every 100 CNY of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against the industry (Chemicals - Specialty)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 228.0 CNY for 1 CNY of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (CNY)
Diluted EPS (CNY)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 16% a year.
Growth in detailDoes it make money?
PoorlyWhere 100 CNY of revenue goes
- Cost of sales 97 CNY
- Research and development 6.9 CNY
- Sales and administration -6.7 CNY
- Taxes and other 1.2 CNY
- Net profit 1.4 CNY
Net profit, industry median (Chemicals - Specialty) 34 CNY
Out of every 100 CNY of revenue, 1.4 CNY is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 181.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 0.25%
- Paid out of profit
- 57%
You receive ¥0.05 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail